Microglia Shape-Shift Between Hidden States That Drive Brain Disease Risk
A landmark review reveals microglia operate through covert reprogrammed states—shaped by aging, sex, and past infections—that explain why brain diseases vary so dramatically between individuals.
Summary
Microglia, the brain's resident immune cells, are far more complex than the old 'resting vs. activated' binary suggested. This 2026 Nature Reviews Neuroscience review synthesizes advances in single-cell transcriptomics, chromatin profiling, and spatial multi-omics to map a rich landscape of microglial states spanning normal brain maintenance through neurodegeneration and infection. Critically, the authors introduce the concept of 'hidden' or covert microglial states—latent programs that look normal at baseline but are revealed under stress, and are durably shaped by aging, genetics, sex, brain region, and prior exposures like sepsis or viral infection. These covert states may explain why individuals with similar genetics develop very different neurodegenerative disease trajectories. The review calls for standardized state annotation and new biomarker strategies targeting these reprogrammed microglial populations.
Detailed Summary
Microglia are the brain's frontline immune sentinels, and for decades they were characterized simplistically as either resting or activated, pro- or anti-inflammatory. This comprehensive 2026 review in Nature Reviews Neuroscience by Eggen and Kooistra dismantles those binary frameworks and presents a far more nuanced, multidimensional picture of microglial biology with direct relevance to aging and neurological disease.
Drawing on rapid advances in single-cell and single-nucleus RNA sequencing, chromatin accessibility profiling (ATAC-seq), and spatial multi-omics, the authors show that microglia occupy a continuous, high-dimensional state space. These states are molded by developmental stage, brain region, biological sex, chronological age, individual genotype, and environmental history—making each person's microglial landscape essentially unique.
The review's most consequential contribution is its mechanistic framework for 'covert' or hidden microglial states. These are latent transcriptional programs that appear homeostatic under normal conditions but are unmasked by immune challenges. Crucially, prior exposures—including sepsis, viral infections like COVID-19, or even chronic systemic inflammation—can epigenetically reprogram microglia through innate immune training or tolerance, leaving lasting imprints on how these cells respond to future insults.
This covert reprogramming offers a compelling explanation for interindividual variability in neurodegenerative disease trajectories. Two people with identical APOE or TREM2 genotypes may have dramatically different Alzheimer's or Parkinson's outcomes partly because their microglia carry different epigenetic histories shaped by past infections or inflammatory events.
The authors conclude by identifying key priorities: harmonizing microglial state annotations across species and data modalities, and translating state-resolved insights into actionable biomarkers and targeted interventions. This review sets a research agenda that could fundamentally reshape how neurodegeneration is predicted, monitored, and treated.
Key Findings
- Single-cell omics reveals microglia occupy a multidimensional state space, not a simple resting/activated binary.
- Covert microglial states—epigenetically shaped by past infections, sepsis, or inflammation—may drive variable disease risk.
- Age, sex, brain region, and genotype each independently sculpt microglial transcriptional identity.
- Innate immune training and tolerance mechanisms durably reprogram microglia after systemic immune challenges.
- Standardized cross-species state annotation is identified as a critical unmet need for translational progress.
Methodology
This is a narrative and synthesis review, not a primary data study. The authors integrate findings from single-cell RNA sequencing, single-nucleus transcriptomics, ATAC-seq chromatin profiling, and spatial multi-omics studies across multiple laboratories and model systems. Evidence is drawn from human and rodent studies spanning neurodegeneration, demyelination, infection, and aging contexts.
Study Limitations
As a review based solely on the abstract, primary data and effect sizes cannot be evaluated. The 'covert state' framework, while mechanistically plausible, remains largely inferential and requires prospective validation in human cohorts. Translation of rodent microglial state findings to human disease may be limited by species differences in microglial biology.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: